Nasdaq:US$19.14 (+0.73) | HKEX:HK$30.35 (+1.05) | AIM:£3.04 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models